Skip to main content
search

Move your program forward with confidence

Early clinical

Success of early clinical trials are linked to strategic planning

Successful early clinical trials depend on strategic design, informed planning, and a clear clinical development roadmap. Certara helps you optimize First-in-Human (FIH) study design, clinical trial protocols, and development plans to minimize risk and improve decision-making. By leveraging our expertise in profiling drug behavior, anticipating variability, and refining trial design, we empower you to enhance success rates and accelerate your path to approval.

Build your evidence and insights

Explore dosing options

Leverage biosimulation to predict responses, analyze data, and refine strategies to design more efficient early-phase trials.

Robust data insights

Transform complex data into actionable insights through advanced pharmacometric modeling and expert consulting services.

Regulatory readiness

Execute your comprehensive clinical development plan, streamline data validation, and prepare regulatory-ready submissions.

Your trusted guide to early clinical success

Certara’s expertise and world-class biosimulation capabilities optimize First-in-Human (FIH) studies and clinical development plans.

  • Refine Dosing & Trial Design with industry-leading platforms like Simcyp Simulator and Phoenix PK/PD to enhance decision-making.
  • Strengthen Regulatory Submissions using validated standards for trial design, data analysis, and compliance.
  • Gain Expert Insights to confirm dosing strategies, assess drug interactions, and predict outcomes in special populations.

Certara is crucial in the majority of trials

From providing the bedrock of predicted pharmacokinetics of cancer drugs to resolving the mass of data from Covid-19 clinical trials, our platforms and consulting provide the prerequisites for success of countless trials and submissions.

11
regulatory agencies have adopted Phoenix
120
novel drugs used Simcyp for approval
85
faster study validation with Pinnacle 21

Looking at the solutions [Certara] are implementing to increase the speed of drug development, is something that is very exciting. Certara is doing some very cool things with AI, especially, that is going to make that space the next evolution of drug development.

Charles River Laboratories

Jocelyn Webb
Charles River Laboratories

Partner with Certara for early clinical success

Gain a competitive edge with Certara’s world class biosimulation platforms and expert services tailored to your early clinical challenges.

Streamline your clinical trial design with trusted PK/PD data analysis and simulation tools like Simcyp and Phoenix.
Optimize dosing strategies for special populations with cutting-edge biosimulation expertise.
Accelerate regulatory submission readiness with platforms trusted by global agencies like Pinnacle 21.

Send an Inquiry